Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Sweden Q3 Pretax Profit Increases To SEK 2.6 Million

Nov 20 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q3 OPERATING REVENUE SEK 110,718
    * Q3 PRETAX PROFIT SEK 2.6 MILLION VERSUS SEK 1.2 MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr94PhCT 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Bio Vitos Pharma AB

See all news